loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Lipoprotein Lipase Activator

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Lipoprotein Lipase Activator

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Daiichi Sankyo’s SANTORINI Study Gets Underway, Investigating Cholesterol Care
    Daiichi Sankyo’s SANTORINI Study Gets Underway, Investigating Cholesterol Care

    09 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200610005045/en

    BUSINESSWIRE
    09 Jun 2020
    Share Share
    Novartis announces NEJM publication of three pivotal trials showing durable
    Novartis announces NEJM publication of three pivotal trials showing durable

    18 Mar 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/novartis-announces-nejm-publication-of-three-pivotal-trials-showing-durable-and-potent-efficacy-of-inclisiran-an-investigational-first-in-class-sirna-cholesterol-lowering-therapy-301026481.html

    PRNEWSWIRE
    18 Mar 2020
    Share Share